Activation of transforming growth factor-β1 and early atherosclerosis in systemic lupus erythematosus

被引:32
|
作者
Jackson, Michelle
Ahmad, Yasmeen
Bruce, Ian N.
Coupes, Beatrice
Brenchley, Paul E. C.
机构
[1] Manchester Royal Infirm, Manchester Inst Nephrol & Transplantat, Renal Res Labs, Manchester M13 9WL, Lancs, England
[2] Univ Manchester, Manchester Royal Infirm, Cent Manchester & Manchester Childrens Univ NHS T, Rheumatism Res Ctr, Manchester M13 9WL, Lancs, England
基金
英国惠康基金;
关键词
D O I
10.1186/ar1951
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The efficiency of activating latent transforming growth factor (TGF)-beta(1) in systemic lupus erythematosus (SLE) may control the balance between inflammation and fibrosis, modulating the disease phenotype. To test this hypothesis we studied the ability to activate TGF-beta(1) in SLE patients and control individuals within the context of inflammatory disease activity, cumulative organ damage and early atherosclerosis. An Activation Index ( AI) for TGF-beta(1) was determined for 32 patients with SLE and 33 age-matched and sex-matched control individuals by quantifying the increase in active TGF-beta(1) under controlled standard conditions. Apoptosis in peripheral blood mononuclear cells was determined by fluorescence-activated cell sorting. Carotid artery intima-media thickness was measured using standard Doppler ultrasound. These measures were compared between patients and control individuals. In an analysis conducted in patients, we assessed the associations of these measures with SLE phenotype, including early atherosclerosis. Both intima-media thickness and TGF-beta(1) AI for SLE patients were within the normal range. There was a significant inverse association between TGF-beta(1) AI and levels of apoptosis in peripheral blood mononuclear cells after 24 hours in culture for both SLE patients and control individuals. Only in SLE patients was there a significant negative correlation between TGF-beta(1) AI and low-density lipoprotein cholesterol ( r = - 0.404; P = 0.022) and between TGF-beta(1) AI and carotid artery intima-media thickness ( r = - 0.587; P = 0.0004). A low AI was associated with irreversible damage (SLICC [ Systemic Lupus International Collaborating Clinics] Damage Index = 1) and was inversely correlated with disease duration. Intima-media thickness was significantly linked to total cholesterol ( r = 0.371; P = 0.037). To conclude, in SLE low normal TGF-beta(1) activation was linked with increased lymphocyte apoptosis, irreversible organ damage, disease duration, calculated low-density lipoprotein levels and increased carotid IMT, and may contribute to the development of early atherosclerosis.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Activation of transforming growth factor-β1and early atherosclerosis in systemic lupus erythematosus
    Michelle Jackson
    Yasmeen Ahmad
    Ian N Bruce
    Beatrice Coupes
    Paul EC Brenchley
    Arthritis Research & Therapy, 8
  • [2] Transforming growth factor-β2 polymorphism and systemic lupus erythematosus
    Alansari, A
    Hajeer, A
    Teh, LS
    Bayat, A
    Mysercough, A
    Gül, A
    Inanc, M
    Ordi-Ros, J
    Ollier, W
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (06) : 1189 - 1191
  • [3] Transforming growth factor- β 1 gene polymorphism in systemic lupus erythematosus female patients
    Abouelazm, Maha A.
    Fadda, Samia M. H.
    Doudar, Noha A.
    Rady, Shaimaa A. K.
    EGYPTIAN RHEUMATOLOGIST, 2024, 46 (03): : 117 - 120
  • [4] Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
    Fuensanta Gómez-Bernal
    Juan Carlos Quevedo-Abeledo
    María García-González
    Yolanda Fernández-Cladera
    Agustín F. González-Rivero
    Candelaria Martín-González
    Miguel Á. González-Gay
    Iván Ferraz-Amaro
    Arthritis Research & Therapy, 25
  • [5] Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
    Gomez-Bernal, Fuensanta
    Quevedo-Abeledo, Juan Carlos
    Garcia-Gonzalez, Maria
    Fernandez-Cladera, Yolanda
    Gonzalez-Rivero, Agustin F.
    Martin-Gonzalez, Candelaria
    Gonzalez-Gay, Miguel A.
    Ferraz-Amaro, Ivan
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [6] Levels of Transforming Growth Factor-β Are Low in Systemic Lupus Erythematosus Patients with Active Disease
    Becker-Merok, Andrea
    Eilertsen, Gro Ostli
    Nossent, Johannes C.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (10) : 2039 - 2045
  • [7] The transforming growth factor-β1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus
    Schotte, H
    Willeke, P
    Rust, S
    Assmann, G
    Domschke, W
    Gaubitz, M
    Schlüter, B
    LUPUS, 2003, 12 (02) : 86 - 92
  • [8] The relationship between defects in lymphocyte production of transforming growth factor-β1 in systemic lupus erythematosus and disease activity or severity
    Ohtsuka, K
    Gray, JD
    Stimmler, MM
    Horwitz, DA
    LUPUS, 1999, 8 (02) : 90 - 94
  • [9] Serum levels of transforming growth factor-β1 (TGF-β1) in patients with systemic lupus erythematosus and Hashimoto's thyroiditis
    Manolova, Irena
    Gerenova, Julieta
    Ivanova, Mariana
    EUROPEAN CYTOKINE NETWORK, 2013, 24 (01) : 69 - 74
  • [10] Transforming Growth Factor-β Level: Indicator for Severity of Disease and Organ Damage in Patients with Systemic Lupus Erythematosus
    Zheng, Song Guo
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (10) : 1983 - 1985